|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sensitivity,specificity,and stability of CSF-tau in AD in a community-based patient sample显示文摘 | Andreasen N Minthon L Clarberg A | 1999 | Neurology1999，22，： | 1 |
| 2 | The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies显示文摘 | Andersson M Hansson O Minthon L | 2008 | Int J Geriatr Psychiatr2008，23，2： | 1 |
| 3 | Cerebrospinal fluid lev- els of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia显示文摘 | Buchhave P Minthon L Zetterberg H | 2012 | Arch Gen Psy- chiatry2012，69，1： | 1 |
| 4 | Vagus nerve stimula- tion in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year显示文摘 | Merrill C A Jonsson M A Minthon L | 2006 | Clin Psych2006，67，： | 1 |
| 5 | Cerebrospinal fluid tau and A-beta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment显示文摘 | Andreasen N Minthon L Vanmechelen E | 1999 | Neurosci Lett1999，273，： | 1 |
| 6 | Processing of neu- ropeptide Y, galanin, and somatostatin in the eerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia 显示文摘 | Nilsson C L Brinkmalm A Minthon L | 2001 | Peptides2001，22，12： | 1 |
| 7 | Results of the first-in-man study with the active Abeta immunotherapy CAD106 in Alzheimer patients显示文摘 | Winblad BG Minthon L Floesser A | 2009 | Alzheimer Dement2009，5，4： | 1 |
| 8 | Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment :six-year follow-up study显示文摘 | Palmqvist S Hertze J Minthon L | 2012 | PLoS One2012，7，38： | 1 |
| 9 | Cere- brospinal fluid levels of fl-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of alzhei- mer dementia显示文摘 | BUCHHAVE P MINTHON L ZET'FERBERG H | 2012 | Arch Gen Psychiatry2012，69，1： | 1 |
| 10 | Cerebral pattern of pro and anti-inflammatory cytokines in dementias显示文摘 | Tarkowski E Liljeroth AM Minthon L | 2003 | Brain Res Bull2003，61，3： | 1 |
| 11 | Evaluation of CSF tau and Aβ 1- 42 as diagnostic markers for Alzheimer's disease in clinical practice显示文摘 | ANDREASEN N MINTHON L DAVIDSSON P | 2001 | Archives of Neurology2001，58，3： | 1 |
| 12 | Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer' s disease 显示文摘 | Bjorkqvist M Ohlsson M Minthon L | 2012 | PLoS One2012，7，29： | 1 |
| 13 | Inflammatory markers in Matched plasma and cerebrospinal fluid from patients with Alzheimer's disease显示文摘 | YX Sun Minthon L Wallmark A | | 0，，： | 1 |
| 14 | Sensitivity specificity and stability of CSF tau in AD in a community based patient sample显示文摘 | ANDREASEN N MINTHON L CLARBERG A | 1999 | Neurology1999，53，7： | 1 |
| 15 | Cerebral pattern of pro-and anti-inflammatory cytokines in dementias显示文摘 | TARKOWSKI E LILJEROTH A M MINTHON L | 2003 | Brain Res Bull2003，61，3： | 1 |
| 16 | Sensitivity,specificity,and stability of CSF-tau in AD in a community-based patient sample显示文摘 | Andreasen N Minthon L Clarberg A | 1999 | Neurology1999，53，： | 1 |
| 17 | The cognitive pro- file and CSF biomarkers in dementia with lewy bodies and Parkin- son's disease dementia 显示文摘 | Andersson M Zetterberg H Minthon L | 2011 | Int J Geriatr Psychiatry2011，26，1： | 1 |
| 18 | Cere- brospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia显示文摘 | Buchhave P Minthon L Zetterberg H | 2012 | Arch Gen Psychiatry2012，69，1： | 1 |
| 19 | Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice显示文摘 | Andreasen N Minthon L Davidsson P | 2001 | Arch Neurol2001，58，： | 1 |
| 20 | Cerebral pattern of pro- and anti-inflammatory cytokines in dementias 显示文摘 | Tarkowski E Liljeroth AM Minthon L | 2003 | Brain Res Bull2003，61，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员